Collect

Must submit both tumor/affected tissue AND a normal/germline specimen. 

For Solid Tumor Specimens:
Fresh Tissue: 150 mg or 0.5-2.0 cm3 fresh tissue in transport media. Delivery within 24 hours at room temperature. 

Fresh Frozen Tissue: 150 mg or 0.5-2.0 cm3 tissue snap frozen at -20°C. Store at -20°C. Ship on minimum of 10 lbs. of dry ice in an insulated container by overnight courier. 

Formalin-fixed, paraffin embedded (FFPE) tissue: a minimum of freshly cut 6 20-um scrolls or 10 slides can be shipped overnight to the laboratory. It would be best to cut and ship Monday to be delivered to us on Tuesday. The laboratory may reach out if additional material is required in case of extraction failure. Please note: unlike the other specimens in which isolated RNA is extracted, only Total Nucleic Acid (DNA and RNA) is extracted from FFPE tissue.

For Normal/Unaffected Specimens: 
Blood: 3-5 ml whole blood in an EDTA (lavender top) tube
Fresh tissue, such as a skin biopsy, is also acceptable as a germline specimen. 



 

Specimen Preparation

See "Collect" section above.

Storage/Transport Temperature

See "Collect" section above.

Volume Required

See "Collect" section above.

Minimum Required

See "Collect" section above.

Phlebotomy Draw

No

Performing Lab

Division of Genomic Diagnostics

Performed

Monday-Friday 9:00am - 4:00pm

Reported

21 days.

Detection Rate

The Paired Tumor/Normal - Comprehensive Solid Tumor Panel includes the V2.1 Solid Tumor Panel for sequence and copy number analyses of 237 cancer genes and two genes associated with cancer pharmacogenomics in paired tumor and normal samples, and V3 Fusion Panel which targets over 700 exons of 117 cancer genes in tumor sample only. 
 

Utility

Facilitates disease diagnosis, risk stratification, and therapeutic decision-making.

Synonyms

  • COMPC
  • Solid Tumor, Fusion panel, Tumor / Normal Paired Test, T/ N, T/N, Comprehensive
  • ABL1, ACVR1, AKT1, AKT2, AKT3, ALK, APC, AR, ARAF, ARID1A, ARID1B, ARID2, ASXL1, ATM, ATR, ATRX, AURKA, AURKB, AXIN1, AXL, B2M, BAP1, BARD1, BCL2, BCL6, BCOR, BCORL1, BLM, BRAF, BRCA1, BRCA2, BRD4, BRIP1, CARD11, CBFB, CBL, CCND1, CCND2, CCND3, CCNE1, CD274, CD79B, CDC73, CDK12, CDK4, CDK6, CDK8, CDKN1B, CDKN2A, CDKN2B, CDKN2C, CHEK1, CHEK2, CIC, CREBBP, CRKL, CRLF2, CSF1R, CTCF, CTNNB1, DAXX, DDR2, DICER1, DNMT3A, DOT1L, EED, EGFR, EP300, EPHA3, EPHA5, EPHB1, ERBB2, ERBB3, ERBB4, ERG
  • ESR1, ETV6, EZH2, FANCA, FANCC, FBXW7, FGF19, FGF3, FGF4, FGFR1, FGFR2, FGFR3, FGFR4, FLCN, FLT1, FLT3, FLT4, FOXL2, FOXP1, FUBP1, GATA1, GATA2, GATA3, GNA11, GNAQ, GNAS, GRIN2A, GSK3B, HGF, HNF1A, HRAS, H1-2, H3C2, H3-3A, IDH1, IDH2, IGF1R, IKBKE, IKZF1, IL7R, INPP4B, IRF4, IRS2, JAK1, JAK2, JAK3, JMJD1C, JUN, KDM5A, KDM5C, KDM6A, KDR, KEAP1, KIT, KMT2A, KMT2C, KRAS, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAPK1, MCL1, MDM2, MDM4, MED12, MEF2B, MEN1, MET, MITF, MLH1, MPL, MRE11 (MRE11A), MSH2, MSH6
  • MTOR, MUTYH, MYB, MYC, MYCN, MYD88, MYOD1, NF1, NF2, NFE2L2, NKX2-1, NOTCH1, NOTCH2, NPM1, NRAS, NSD2 (WHSC1), NTRK1, NTRK2, NTRK3, PALB2, PAX5, PBRM1, PDCD1, PDGFRA, PDGFRB, PHOX2B, PIK3CA, PIK3CG, PIK3R1, PIK3R2, PIM1, PPM1D, PPP2R1A, PRDM1, PRKAR1A, PTCH1, PTEN, PTPN11, RAD50, RAD51, RAF1, RARA, RB1, RET, RHOA, RICTOR, RNF43, ROS1, RPTOR, RUNX1, SDHA, SDHB, SDHC, SDHD, SETD2, SF3B1, SMAD2, SMAD4, SMARCA4, SMARCB1, SMO, SOCS1, SOX2, SPEN, SPOP, SRC, STAG2, STK11, SUFU, SUZ12, TENT5C (FAM46C)
  • TERT, TET2, TGFBR2, TNFAIP3, TNFRSF14, TOP1, TP53, TP63, TSC1, TSC2, TSHR, U2AF1, VHL, WT1, AMER1, XPO1, NUDT15, TPMT, ABL2, ARHGAP26, BCR, BRD3, CAMTA1, CBFA2T3, CCNB3, DNAJB1, DUSP22, EGFR, EPC1, EPOR, ESRRA, ETV1, ETV4, ETV5, EWSR1, FGR, FOXO1, FUS, GLI1, GLIS2, HMGA2, IL2RB, IL3, IL3RA, INSR, JAZF1, KAT6A, MALT1, MAML2, MAST1, MAST2, MEAF6, MECOM, MRTFA, MRTFB, MSMB, MUSK, NCOA2, NRG1, NUMBL, NUP214, NUP98, NUTM1, PAX8, PDGFB, PICALM, PKN1, PLAG1, PPARG, PRKACA, PRKCA, PRKCB, PTK2B, RBM15
  • RELA, RSPO2, RSPO3, RUNX1T1, SS18, STAT6, TAF15, TAL1, TCF12, TCF3, TFE3, TFEB, TFG, THADA, TLX3, TMPRSS2, TSLP, TYK2, USP6, VGLL2, YWHAE, Chr19q13.42 (C19MC)

LIS Mnemonic

COMPC

Available STAT

Yes

Test Notes

Next generation sequencing (NGS) and data analysis: Nucleic acid is extracted from the patient’s samples following standard DNA and RNA extraction protocols. Extracted DNA is fragmented and tagged using SureSelect QXT target enrichment to generate adapter-tagged libraries. Biotin-labeled probes specific to the targeted regions are used for capture hybridization. Libraries are enriched for the desired regions using streptavidin beads. Enriched libraries are then indexed and pooled for sequencing. Libraries are subject to sequence analysis on Illumina NovaSeq 6000 system for 150 bp paired end reads. All coding exons and the flanking intron sequences of targeted genes in the panel are sequenced, and selected promoter regions and known intronic variants are also evaluated. Sequence data are analyzed using the home brew software ConcordS V4.0.0 and NextGENe V2 NGS Analysis Software. Sequence variants within exons and 5 bp flanking intron sequences are annotated. Copy number variation (CNV) analysis for gross deletions and duplications are evaluated using NGS data. For the tumor sample only, RNA sequencing libraries are prepared using Archer Universal RNA Reagent Kit with CHOP fusion panel custom-designed primers with target specific molecular barcode. Sequencing data are analyzed using ArcherTM Analysis for fusion genes. Clinically significant variants including single nucleotide variants (SNVs), indels, CNVs and fusion genes are confirmed by Sanger sequencing, MLPA, Real-Time PCR, or ddPCR only when necessary.

Molecular Testing Notes

The genes included in the V2.1 Solid Tumor Panel (GRCh38): ABL1, ACVR1, AKT1, AKT2, AKT3, ALK, APC, AR, ARAF, ARID1A, ARID1B, ARID2, ASXL1, ATM, ATR, ATRX, AURKA, AURKB, AXIN1, AXL, B2M, BAP1, BARD1, BCL2, BCL6, BCOR, BCORL1, BLM, BRAF, BRCA1, BRCA2, BRD4, BRIP1, CARD11, CBFB, CBL, CCND1, CCND2, CCND3, CCNE1, CD274, CD79B, CDC73, CDK12, CDK4, CDK6, CDK8, CDKN1B, CDKN2A, CDKN2B, CDKN2C, CHEK1, CHEK2, CIC, CREBBP, CRKL, CRLF2, CSF1R, CTCF, CTNNB1, DAXX, DDR2, DICER1, DNMT3A, DOT1L, EED, EGFR, EP300, EPHA3, EPHA5, EPHB1, ERBB2, ERBB3, ERBB4, ERG, ESR1, ETV6, EZH2, FANCA, FANCC, FBXW7, FGF19, FGF3, FGF4, FGFR1, FGFR2, FGFR3, FGFR4, FLCN, FLT1, FLT3, FLT4, FOXL2, FOXP1, FUBP1, GATA1, GATA2, GATA3, GNA11, GNAQ, GNAS, GRIN2A, GSK3B, HGF, HNF1A, HRAS, H1-2, H3C2, H3-3A, IDH1, IDH2, IGF1R, IKBKE, IKZF1, IL7R, INPP4B, IRF4, IRS2, JAK1, JAK2, JAK3, JMJD1C, JUN, KDM5A, KDM5C, KDM6A, KDR, KEAP1, KIT, KMT2A, KMT2C, KRAS, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAPK1, MCL1, MDM2, MDM4, MED12, MEF2B, MEN1, MET, MITF, MLH1, MPL, MRE11 (MRE11A), MSH2, MSH6, MTOR, MUTYH, MYB, MYC, MYCN, MYD88, MYOD1, NF1, NF2, NFE2L2, NKX2-1, NOTCH1, NOTCH2, NPM1, NRAS, NSD2 (WHSC1), NTRK1, NTRK2, NTRK3, PALB2, PAX5, PBRM1, PDCD1, PDGFRA, PDGFRB, PHOX2B, PIK3CA, PIK3CG, PIK3R1, PIK3R2, PIM1, PPM1D, PPP2R1A, PRDM1, PRKAR1A, PTCH1, PTEN, PTPN11, RAD50, RAD51, RAF1, RARA, RB1, RET, RHOA, RICTOR, RNF43, ROS1, RPTOR, RUNX1, SDHA, SDHB, SDHC, SDHD, SETD2, SF3B1, SMAD2, SMAD4, SMARCA4, SMARCB1, SMO, SOCS1, SOX2, SPEN, SPOP, SRC, STAG2, STK11, SUFU, SUZ12, TENT5C (FAM46C), TERT, TET2, TGFBR2, TNFAIP3, TNFRSF14, TOP1, TP53, TP63, TSC1, TSC2, TSHR, U2AF1, VHL, WT1, AMER1, and XPO1. The panel also includes coverage of the Chr19q13.42 (C19MC) region  and two cancer-associated pharmacogenomics genes (genotyping only): NUDT15 and TPMT.

The genes included in the V3 Fusion Panel (GRCh37): ABL1, ABL2, AKT3, ALK, ARHGAP26, AXL, BCL2, BCL6, BCR, BRAF, BRD3, BRD4, CAMTA1, CBFA2T3, CBFB, CCNB3, CCND1, CIC, CREBBP, CRFL2, CSF1R, DNAJB1, DUSP22, EGFR, EPC1, EPOR, ERG, ESR1, ESRRA, ETV1, ETV4, ETV5, ETV6, EWSR1, FGFR1, FGFR2, FGFR3, FGR, FOXO1, FUS, GLI1, GLIS2, HMGA2, IL2RB, IL3, IL3RA, INSR, JAK2, JAZF1, KAT6A, KMT2A, MALT1, MAML2, MAST1, MAST2, MEAF6, MECOM, MET, MRTFA, MRTFB, MSMB, MUSK, MYB, MYC, NCOA2, NOTCH1, NOTCH2, NRG1, NTRK1, NTRK2, NTRK3, NUMBL, NUP214, NUP98, NUTM1, PAX5, PAX8, PDGFB, PDGFRA, PDGFRB, PICALM, PIK3CA, PKN1, PLAG1, PPARG, PRKACA, PRKCA, PRKCB, PTK2B, RAF1, RARA, RBM15, RELA, RET, ROS1, RSPO2, RSPO3, RUNX1, RUNX1T1, SS18, STAT6, TAF15, TAL1, TCF12, TCF3, TERT, TFE3, TFEB, TFG, THADA, TLX3, TMPRSS2, TSLP, TYK2, USP6, VGLL2, YWHAE.

CPT Codes

81455
Collection

Collect

Must submit both tumor/affected tissue AND a normal/germline specimen. 

For Solid Tumor Specimens:
Fresh Tissue: 150 mg or 0.5-2.0 cm3 fresh tissue in transport media. Delivery within 24 hours at room temperature. 

Fresh Frozen Tissue: 150 mg or 0.5-2.0 cm3 tissue snap frozen at -20°C. Store at -20°C. Ship on minimum of 10 lbs. of dry ice in an insulated container by overnight courier. 

Formalin-fixed, paraffin embedded (FFPE) tissue: a minimum of freshly cut 6 20-um scrolls or 10 slides can be shipped overnight to the laboratory. It would be best to cut and ship Monday to be delivered to us on Tuesday. The laboratory may reach out if additional material is required in case of extraction failure. Please note: unlike the other specimens in which isolated RNA is extracted, only Total Nucleic Acid (DNA and RNA) is extracted from FFPE tissue.

For Normal/Unaffected Specimens: 
Blood: 3-5 ml whole blood in an EDTA (lavender top) tube
Fresh tissue, such as a skin biopsy, is also acceptable as a germline specimen. 



 

Specimen Preparation

See "Collect" section above.

Storage/Transport Temperature

See "Collect" section above.

Volume Required

See "Collect" section above.

Minimum Required

See "Collect" section above.

Phlebotomy Draw

No
Ordering

Performing Lab

Division of Genomic Diagnostics

Performed

Monday-Friday 9:00am - 4:00pm

Reported

21 days.

Detection Rate

The Paired Tumor/Normal - Comprehensive Solid Tumor Panel includes the V2.1 Solid Tumor Panel for sequence and copy number analyses of 237 cancer genes and two genes associated with cancer pharmacogenomics in paired tumor and normal samples, and V3 Fusion Panel which targets over 700 exons of 117 cancer genes in tumor sample only. 
 

Utility

Facilitates disease diagnosis, risk stratification, and therapeutic decision-making.

Synonyms

  • COMPC
  • Solid Tumor, Fusion panel, Tumor / Normal Paired Test, T/ N, T/N, Comprehensive
  • ABL1, ACVR1, AKT1, AKT2, AKT3, ALK, APC, AR, ARAF, ARID1A, ARID1B, ARID2, ASXL1, ATM, ATR, ATRX, AURKA, AURKB, AXIN1, AXL, B2M, BAP1, BARD1, BCL2, BCL6, BCOR, BCORL1, BLM, BRAF, BRCA1, BRCA2, BRD4, BRIP1, CARD11, CBFB, CBL, CCND1, CCND2, CCND3, CCNE1, CD274, CD79B, CDC73, CDK12, CDK4, CDK6, CDK8, CDKN1B, CDKN2A, CDKN2B, CDKN2C, CHEK1, CHEK2, CIC, CREBBP, CRKL, CRLF2, CSF1R, CTCF, CTNNB1, DAXX, DDR2, DICER1, DNMT3A, DOT1L, EED, EGFR, EP300, EPHA3, EPHA5, EPHB1, ERBB2, ERBB3, ERBB4, ERG
  • ESR1, ETV6, EZH2, FANCA, FANCC, FBXW7, FGF19, FGF3, FGF4, FGFR1, FGFR2, FGFR3, FGFR4, FLCN, FLT1, FLT3, FLT4, FOXL2, FOXP1, FUBP1, GATA1, GATA2, GATA3, GNA11, GNAQ, GNAS, GRIN2A, GSK3B, HGF, HNF1A, HRAS, H1-2, H3C2, H3-3A, IDH1, IDH2, IGF1R, IKBKE, IKZF1, IL7R, INPP4B, IRF4, IRS2, JAK1, JAK2, JAK3, JMJD1C, JUN, KDM5A, KDM5C, KDM6A, KDR, KEAP1, KIT, KMT2A, KMT2C, KRAS, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAPK1, MCL1, MDM2, MDM4, MED12, MEF2B, MEN1, MET, MITF, MLH1, MPL, MRE11 (MRE11A), MSH2, MSH6
  • MTOR, MUTYH, MYB, MYC, MYCN, MYD88, MYOD1, NF1, NF2, NFE2L2, NKX2-1, NOTCH1, NOTCH2, NPM1, NRAS, NSD2 (WHSC1), NTRK1, NTRK2, NTRK3, PALB2, PAX5, PBRM1, PDCD1, PDGFRA, PDGFRB, PHOX2B, PIK3CA, PIK3CG, PIK3R1, PIK3R2, PIM1, PPM1D, PPP2R1A, PRDM1, PRKAR1A, PTCH1, PTEN, PTPN11, RAD50, RAD51, RAF1, RARA, RB1, RET, RHOA, RICTOR, RNF43, ROS1, RPTOR, RUNX1, SDHA, SDHB, SDHC, SDHD, SETD2, SF3B1, SMAD2, SMAD4, SMARCA4, SMARCB1, SMO, SOCS1, SOX2, SPEN, SPOP, SRC, STAG2, STK11, SUFU, SUZ12, TENT5C (FAM46C)
  • TERT, TET2, TGFBR2, TNFAIP3, TNFRSF14, TOP1, TP53, TP63, TSC1, TSC2, TSHR, U2AF1, VHL, WT1, AMER1, XPO1, NUDT15, TPMT, ABL2, ARHGAP26, BCR, BRD3, CAMTA1, CBFA2T3, CCNB3, DNAJB1, DUSP22, EGFR, EPC1, EPOR, ESRRA, ETV1, ETV4, ETV5, EWSR1, FGR, FOXO1, FUS, GLI1, GLIS2, HMGA2, IL2RB, IL3, IL3RA, INSR, JAZF1, KAT6A, MALT1, MAML2, MAST1, MAST2, MEAF6, MECOM, MRTFA, MRTFB, MSMB, MUSK, NCOA2, NRG1, NUMBL, NUP214, NUP98, NUTM1, PAX8, PDGFB, PICALM, PKN1, PLAG1, PPARG, PRKACA, PRKCA, PRKCB, PTK2B, RBM15
  • RELA, RSPO2, RSPO3, RUNX1T1, SS18, STAT6, TAF15, TAL1, TCF12, TCF3, TFE3, TFEB, TFG, THADA, TLX3, TMPRSS2, TSLP, TYK2, USP6, VGLL2, YWHAE, Chr19q13.42 (C19MC)

LIS Mnemonic

COMPC

Available STAT

Yes

Test Notes

Next generation sequencing (NGS) and data analysis: Nucleic acid is extracted from the patient’s samples following standard DNA and RNA extraction protocols. Extracted DNA is fragmented and tagged using SureSelect QXT target enrichment to generate adapter-tagged libraries. Biotin-labeled probes specific to the targeted regions are used for capture hybridization. Libraries are enriched for the desired regions using streptavidin beads. Enriched libraries are then indexed and pooled for sequencing. Libraries are subject to sequence analysis on Illumina NovaSeq 6000 system for 150 bp paired end reads. All coding exons and the flanking intron sequences of targeted genes in the panel are sequenced, and selected promoter regions and known intronic variants are also evaluated. Sequence data are analyzed using the home brew software ConcordS V4.0.0 and NextGENe V2 NGS Analysis Software. Sequence variants within exons and 5 bp flanking intron sequences are annotated. Copy number variation (CNV) analysis for gross deletions and duplications are evaluated using NGS data. For the tumor sample only, RNA sequencing libraries are prepared using Archer Universal RNA Reagent Kit with CHOP fusion panel custom-designed primers with target specific molecular barcode. Sequencing data are analyzed using ArcherTM Analysis for fusion genes. Clinically significant variants including single nucleotide variants (SNVs), indels, CNVs and fusion genes are confirmed by Sanger sequencing, MLPA, Real-Time PCR, or ddPCR only when necessary.

Molecular Testing Notes

The genes included in the V2.1 Solid Tumor Panel (GRCh38): ABL1, ACVR1, AKT1, AKT2, AKT3, ALK, APC, AR, ARAF, ARID1A, ARID1B, ARID2, ASXL1, ATM, ATR, ATRX, AURKA, AURKB, AXIN1, AXL, B2M, BAP1, BARD1, BCL2, BCL6, BCOR, BCORL1, BLM, BRAF, BRCA1, BRCA2, BRD4, BRIP1, CARD11, CBFB, CBL, CCND1, CCND2, CCND3, CCNE1, CD274, CD79B, CDC73, CDK12, CDK4, CDK6, CDK8, CDKN1B, CDKN2A, CDKN2B, CDKN2C, CHEK1, CHEK2, CIC, CREBBP, CRKL, CRLF2, CSF1R, CTCF, CTNNB1, DAXX, DDR2, DICER1, DNMT3A, DOT1L, EED, EGFR, EP300, EPHA3, EPHA5, EPHB1, ERBB2, ERBB3, ERBB4, ERG, ESR1, ETV6, EZH2, FANCA, FANCC, FBXW7, FGF19, FGF3, FGF4, FGFR1, FGFR2, FGFR3, FGFR4, FLCN, FLT1, FLT3, FLT4, FOXL2, FOXP1, FUBP1, GATA1, GATA2, GATA3, GNA11, GNAQ, GNAS, GRIN2A, GSK3B, HGF, HNF1A, HRAS, H1-2, H3C2, H3-3A, IDH1, IDH2, IGF1R, IKBKE, IKZF1, IL7R, INPP4B, IRF4, IRS2, JAK1, JAK2, JAK3, JMJD1C, JUN, KDM5A, KDM5C, KDM6A, KDR, KEAP1, KIT, KMT2A, KMT2C, KRAS, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAPK1, MCL1, MDM2, MDM4, MED12, MEF2B, MEN1, MET, MITF, MLH1, MPL, MRE11 (MRE11A), MSH2, MSH6, MTOR, MUTYH, MYB, MYC, MYCN, MYD88, MYOD1, NF1, NF2, NFE2L2, NKX2-1, NOTCH1, NOTCH2, NPM1, NRAS, NSD2 (WHSC1), NTRK1, NTRK2, NTRK3, PALB2, PAX5, PBRM1, PDCD1, PDGFRA, PDGFRB, PHOX2B, PIK3CA, PIK3CG, PIK3R1, PIK3R2, PIM1, PPM1D, PPP2R1A, PRDM1, PRKAR1A, PTCH1, PTEN, PTPN11, RAD50, RAD51, RAF1, RARA, RB1, RET, RHOA, RICTOR, RNF43, ROS1, RPTOR, RUNX1, SDHA, SDHB, SDHC, SDHD, SETD2, SF3B1, SMAD2, SMAD4, SMARCA4, SMARCB1, SMO, SOCS1, SOX2, SPEN, SPOP, SRC, STAG2, STK11, SUFU, SUZ12, TENT5C (FAM46C), TERT, TET2, TGFBR2, TNFAIP3, TNFRSF14, TOP1, TP53, TP63, TSC1, TSC2, TSHR, U2AF1, VHL, WT1, AMER1, and XPO1. The panel also includes coverage of the Chr19q13.42 (C19MC) region  and two cancer-associated pharmacogenomics genes (genotyping only): NUDT15 and TPMT.

The genes included in the V3 Fusion Panel (GRCh37): ABL1, ABL2, AKT3, ALK, ARHGAP26, AXL, BCL2, BCL6, BCR, BRAF, BRD3, BRD4, CAMTA1, CBFA2T3, CBFB, CCNB3, CCND1, CIC, CREBBP, CRFL2, CSF1R, DNAJB1, DUSP22, EGFR, EPC1, EPOR, ERG, ESR1, ESRRA, ETV1, ETV4, ETV5, ETV6, EWSR1, FGFR1, FGFR2, FGFR3, FGR, FOXO1, FUS, GLI1, GLIS2, HMGA2, IL2RB, IL3, IL3RA, INSR, JAK2, JAZF1, KAT6A, KMT2A, MALT1, MAML2, MAST1, MAST2, MEAF6, MECOM, MET, MRTFA, MRTFB, MSMB, MUSK, MYB, MYC, NCOA2, NOTCH1, NOTCH2, NRG1, NTRK1, NTRK2, NTRK3, NUMBL, NUP214, NUP98, NUTM1, PAX5, PAX8, PDGFB, PDGFRA, PDGFRB, PICALM, PIK3CA, PKN1, PLAG1, PPARG, PRKACA, PRKCA, PRKCB, PTK2B, RAF1, RARA, RBM15, RELA, RET, ROS1, RSPO2, RSPO3, RUNX1, RUNX1T1, SS18, STAT6, TAF15, TAL1, TCF12, TCF3, TERT, TFE3, TFEB, TFG, THADA, TLX3, TMPRSS2, TSLP, TYK2, USP6, VGLL2, YWHAE.
Result Interpretation
Administrative

CPT Codes

81455